Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients starting with the eye
Irvine, CA
Joined January 2020
- Tweets379
- Following162
- Followers656
- Likes123
Tarsus has announced its Q3 2026 financial results and business updates. Read the announcement: bit.ly/47XtyqA
84
Join us on November 3 at 1:30PM PT as Tarsus shares its Q3 2026 financial results and key business updates. Tune into the live webcast: bit.ly/46rBYot
1
184
Today, Tarsus announced the acquisition of iRenix Medical, a clinical-stage ophthalmic biopharmaceutical company. This exciting milestone builds on our commitment to advancing innovation across eye care. Read more: bit.ly/4w4A4pC
1
2
350
Join us on May 6 at 1:30PM PT as Tarsus shares its Q1 2026 financial results and key business updates. Tune into the live webcast: bit.ly/42J9EwB
172
Today we announced that the first participant has been dosed in a Phase 2 clinical trial for an investigational oral therapeutic designed to potentially prevent Lyme disease by killing Lyme-infected ticks before disease transmission occurs. Learn more: bit.ly/4dkZWqW
We are pleased to announce that approval of our Demodex blepharitis treatment in Greater China has been secured by Grand Pharmaceutical Group Limited, our exclusive regional partner.
Read the full announcement here: bit.ly/4d0wp5P
2
192
Read through our Q4 and full year 2025 earnings announcement here: bit.ly/3ZWPrSO
Listen in on February 23 at 1:30 PM PT as Tarsus reports its Q4 and full-year 2025 financial results and business achievements.
Tune into the live webcast here: bit.ly/46rBYot
Check out our Q3 2025 earnings announcement here: bit.ly/493hMN8
Tune in on Tuesday, November 4 at 1:30pm PT as Tarsus announces our Q3 financial results and business accomplishments. Stream the live webcast: bit.ly/4nqlR1i
Read through our Q2 2025 earnings announcement here: bit.ly/4ldYxTm
Tune in on Wednesday, August 6, as we share our Q2 2025 financial results. Watch the live broadcast here: bit.ly/41jkysL
Read through our Q1 2025 earnings announcement here: bit.ly/3ERwKcd
Tune in on Thursday, May 1, as we share our Q1 2025 financial results and business achievements. Watch the live broadcast here: bit.ly/44FgSUF
209
Join us in Los Angeles at the upcoming @ASCRStweets Annual Meeting to learn about exciting results from four of our eye care studies. Learn more: ir.tarsusrx.com/news-release… #ASCRS2025
1
212
Did you catch us @seco_intl? We had an incredible week in Atlanta talking firsthand with eye care professionals. Can't wait to turn insights into action and for next year's SECO! #SeeItAtSECO
222
Read through our Q4 and full year 2024 earnings announcement here: ir.tarsusrx.com/news-release…
169
Join us on Tuesday, February 25, at 5 a.m. PT as we share our Q4 and full year 2024 financial results and business achievements. Watch the live webcast here: ir.tarsusrx.com/events-and-p…
197
We’re back from an amazing time at @aaopt! We are so thankful for the opportunity to collaborate and learn from experts in the industry.
Watch a few of our Tarsans share their favorite highlights from the meeting. #Academy24
305